Alydia Health is a medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage.
Alydia Health is a medical device company working toward a solution to postpartum hemorrhage (PPH), the number one cause of maternal death. Their single-minded focus is to improve radically the treatment path for postpartum hemorrhage from the traumatic, life-altering condition that it is today. They are devoted to improving the lives of women around the world.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 30, 2020 | Series C | $13.90M | 3 |
|
— | Detail |
| Aug 28, 2018 | Series B | $10.27M | 3 |
Global Health Investment Fund (GHIF)
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
Avestria Ventures
|
— | Series C |
Global Health Investment Fund (GHIF)
|
— | Series C |
Astia Angels
|
— | Series B |
Kimberly Vogel
|
— | Series B |